On March 16, we arranged the first virtual BioStock Investor Meeting of 2022. The event gave representatives from a number of life science companies active in a wide range of therapeutic areas the opportunity to present their business case to investors and potential partners.

Showcasing companies included

• AlzeCure presented by CEO Martin Jönsson
• Aptahem presented by CEO Mikael Lindstam 
• Carbiotix presented by CEO Kristofer Cook
• Emplicure presented by CEO Torbjörn W. Larsson 
• Idogen presented by CEO Anders Karlsson
• Miris presented by CEO Camilla Myhre Sandberg
• Phase Holographic Imaging presented by CEO Peter Egelberg 
• Pharmiva presented by deputy CEO Karoline Akerjordet  
• Prolight Diagnostics presented by CEO Ulf Bladin
• Promore Pharma presented by CEO Jonas Ekblom
• QuiaPEG presented by CEO Marcus Bosson
• Respiratorius presented by CEO Johan Drott 
• Sensidose presented by CEO Jack Spira
• Targinta presented by CEO Per Norlén 

You can also read about BioStock’s other events during 2022 below.